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The sonic hedgehog (SHH) signaling pathway has key roles during embryonic development, cell fate decisions, and tumor formation (Hui and Angers, 2011; Ingham et al., 2011) . SHH binds to its receptor Patched1 (Ptch1), releasing Smoothened (Smo) inhibition that results in Gli-dependent transcription of SHH target genes. Inactivating mutations in Ptch1 in the skin promotes formation of basal cell carcinomas (BCCs) at high frequency and are the cause of Gorlin syndrome in the germline (Hahn et al., 1996) . Although Gorlin patients have well-characterized susceptibility to other SHH-dependent tumors, Ptch1 loss in these patients does not appear to contribute to excessive SCC development. Moreover, sporadic BCCs also rely on high levels of SHH target gene induction for tumor growth, providing the rational for development of a targeted therapy. Indeed, inhibition of the SHH pathway with Smo antagonists recently received Food and Drug Administration approval for the treatment of late advanced or metastatic BCCs, and they have shown impressive efficacy in Gorlin patients (Atwood et al., 2012) . Although the role for Ptch1 in BCC tumor suppression is clear, surprisingly little is known about how this enigmatic protein functions at a mechanistic level. Ptch1 is a member of the sterol-sensing domain family and shares identity with the ABC transporter family (Ingham et al., 2011) . Although this suggests it pumps key signaling molecules, none so far has been identified unequivocably. Moreover, Ptch1 function in suppressing Smo, arguably its most oft-written role, has not been delineated. Although it is clear that SHH binding to Ptch1 activates Smo, how the two proteins interact remains unknown. Initial studies suggested that the two proteins form a complex and argued for direct allosteric inhibition (Carpenter et al., 1998; Murone et al., 1999) . However, later quantitative studies indicated that Ptch1 acts catalytically, suggesting it controls an enzymatic modifier of Smo function (Ingham et al., 2000; Taipale et al., 2002) . Recently, entry into the primary cilium, a microtubule based organelle, has been shown to be important for Smo function, and Ptch1 appears to regulate ciliary entry in an as yet unknown manner (Rohatgi et al., 2007) .
Ptch1
FVB promotes Ras-induced skin tumorigenesis
Distinct from its role in controlling the SHH pathway, recent studies indicate a growing role for Ptch1 in regulating apoptosis. The original role for SHH and Ptch1 in regulating cell survival came from work in the developing neuroepithelium, where SHH acts as a neuronal survival factor (Thibert et al., 2003) . This study demonstrated that Ptch1 induces apoptosis independent of Smo and Gli activity by acting as a dependence receptor, binding caspases, and inducing apoptosis.
Work from the Balmain lab illuminates a similar role for the multifunctional protein in skin cancer. Previously, Wakabayashi et al. (2007) , in an elegant forward genetic screen for modifiers of SCC, found that a single-amino-acid variant of Ptch1 (T1267N) confers increased susceptibility to Ras-induced tumor formation in the FVB/N strain of mice. Overexpression of the Ptch1 FVB allele driven by the keratin 14 promoter (K14Ptch1 FVB ) was sufficient to drive Ras-induced formation of SCCs in C57BL/6 mice. In this issue, Kang et al. (2013) show that forced overexpression of K14Ptch1 FVB results in developmental malformations consistent with diminished SHH signaling. Mice displayed shorter body lengths, lower body weights, ocular defects, and oligodactyly with fewer digits with higher K14Ptch1 FVB expression. Although low K14Ptch1 FVB expression did not show pronounced developmental defects, these mice were more stable, and they were used to expand upon the previously reported Ras-induced SCC formation. To determine the contribution of K14Ptch1 FVB in adult onset SCC, Ras was mutated by chemical means (7,12-dimethylbenz[a] anthracene followed by 12-Otetradecanoylphorbol-13-acetate (TPA)) in the skin of adult mice, and tumor formation was measured. This system typically induces somatic mutation in H-Ras at codon 61 (CAA to CTA) at high frequency, causing constitutive activation and SCC formation similar to that which is observed in human skin tumors (Balmain et al., 1984) . The authors found that chemically induced SCC development increased and tumor latency decreased in K14Ptch1 FVB mice compared with wild-type mice, despite no significant change in SHH target gene expression. They concluded that the K14Ptch1 FVB allele contributes to Ras-induced skin tumor development in adult mice. Kang et al. (2013) begin to shed light on how Ptch1 FVB promotes SCC formation through regulation of Rasinduced apoptosis (Figure 1) (Chang et al., 2010) . In light of the observation that TPA promotes P-ERK in the presence of Ptch1 B6 , but inhibits P-ERK when Ptch1 FVB is expressed, additional work is needed to determine whether Ptch1 influences MAP kinase signaling directly.
Ptch1 lies at a nexus between BCC and SCC formation
Identification of the Ptch1 FVB allele suggests that Ptch1 can have roles in both BCC and SCC development, inhibiting BCCs and promoting SCCs. Interestingly, both tumors appear to share a common cell of origin, with the interfollicular epidermis, hair follicle bulge, and hair germ giving rise to both tumors, depending on the genetic environment (Epstein, 2011; Lapouge et al., 2011; White et al., 2011) . In mice, p53 loss instigates tumor growth along with activating signals from either RAS or SHH. Toggling expression of RAS or SHH through Ptch1 FVB , where more Ptch1 leads to inhibition of SHH signaling and promotion of Ras signaling, provides an interesting and simple way in which tumor lineages can use the multiple functions of a single protein to generate distinct outcomes. Although the current study focuses on murine skin cancer, alterations in the Ptch1 locus in human SCCs appear frequently but are of unknown significance. Ptch1 function in preventing apoptosis may be generalizable to other SHH-dependent and well as SHH-independent cancers.
Clinical Implications

Ptch1
FVB is a multifunctional protein that regulates hedgehog signaling and the Ras pathway.
Ptch1 alleles can promote murine SCC development at the same time that they inhibit BCC growth. 
